By Dave Andrusko On September 12, NRLC made a made a major contribution to educating the public in a White Paper that challenged the media’s coverage of a ruling handed down by U.S. Fifth Circuit Court of Appeals: What the Media Missed in Its Coverage of the U.S. Fifth Circuit Court of Appeals Decision Regarding Mifepristone. The …Continue reading "What the Media Missed in Its Coverage of the U.S. Fifth Circuit Court of Appeals Decision Regarding Mifepristone: National Right to Life’s Latest White Paper"
WASHINGTON, D.C.— On Tuesday, September 12, National Right to Life released a white paper challenging the media coverage of the decision in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (FDA) issued by the U.S. Fifth Circuit Court of Appeals in August. In its decision, the Fifth Circuit determined that when the FDA loosened regulations …Continue reading "National Right to Life Releases Its Latest White Paper: What the Media Missed in Its Coverage of the U.S. Fifth Circuit Court of Appeals Decision Regarding Mifepristone"
By Dave Andrusko As expected, on Friday the Biden Administration asked the Supreme Court to review a 5th District Court of Appeals opinion that kept the abortion pill mifepristone available but did place significant restrictions on its distribution. In court papers U.S. Solicitor General Elizabeth Prelogar said that the 5th Circuit had imposed “novel requirements that have no basis” …Continue reading "Biden Administration asks Supreme Court to review 5th Circuit’s ruling that placed significant restrictions on distribution of abortion pill"
By Anna Reynolds In a recent profile in the New York Times, reporter Pam Belluck lays out the dark history of the chemical abortion pill. Meant as a glowing profile of Étienne-Émile Baulieu, known as the “Father of the Abortion Pill,” the article demonstrates the deception used to commercialize lethal pills that have, to date, killed millions of preborn …Continue reading "The “Father of the Abortion Pill” reveals it was always about death"
By Kentucky Right to Life On Wednesday, August 16, the Fifth Circuit Court of Appeals ruled the FDA had overstepped its authority allowing the deadly drugs to be sent by mail. Kentucky Right to Life Executive Director, Addia Wuchner affirmed the Court’s finding, stating, “The three judge panel of the Fifth Circuit Court of Appeals has …Continue reading "U.S. Court of Appeals Rules to Limit Access to the Abortion Pill Mifepristone"
WASHINGTON, D.C.— Late yesterday, the U.S. District Court Judge Robert C. Chambers issued a decision GenBioPro, Inc. v. Sorsaia. In the lawsuit, GenBioPro, a chemical abortion drug manufacturer, challenged West Virginia’s Unborn Child Protection Act claiming that it should be found unconstitutional on the basis that Congress gave the Food and Drug Administration (FDA) authority over state laws …Continue reading "West Virginia District Court Affirms West Virginia’s Right to Stop the Use of Mifepristone"
By Virginia Pride, Secular Pro-Life Earlier in 2023, the Alliance for Hippocratic Medicine [AHM], other pro-life medical organizations, and individual pro-life physicians filed a federal district court in Dallas, against the FDA concerning their regulations on dispensing mifepristone. This drug is the first of two used in the abortion pill sequence, blocking the pregnancy hormone progesterone …Continue reading "Alliance for Hippocratic Medicine vs. FDA: A Quick Run-Down"
Mifepristone was created to starve unborn babies to death and poses significant risks to the mother’s health. While these dangers should have been reason enough not to put this drug out on the market, the FDA was unable to ignore them and originally attached stricter safety regulations to the drug’s use upon approval in 2000. …Continue reading "“Chemical abortion has a complication rate four times higher than surgical abortions”"
By Dave Andrusko District Judge Robert S. Ballou, a federal judge in Virginia, has rejected a petition by abortion clinics in Kansas, Montana, and Virginia, asking the court for a preliminary injunction to block potentially more stringent FDA restrictions on access to mifepristone. Mifepristone is one of two drug that make up chemical abortions—“medication abortions.” According to …Continue reading "Judge rejects petition from abortion providers in three states who sought to block potentially more protective FDA restrictions on access to mifepristone"
By Dave Andrusko You don’t have to read far into Alice Gibbs’ review for Newsweek to know where she is coming from. In fact, under the category “Wellness & Fitness,” the tell-all headline for her story is “Mom Films At-Home Abortion to Destigmatize Termination: ‘Nothing to Hide.’” In her opening sentence, Gibbs gushes “One woman’s courageous decision to …Continue reading "“Take a trip with me on my first abortion at-home”"
Fifth Circuit Court of Appeals rules on merits of case By Rep. Chris Smith (R-NJ), Co-Chair of the Congressional Pro-Life Caucus Editor’s note. Rep. Smith was responding to the ruling by the Fifth Circuit Court of Appeals that, pending consideration by the Supreme Court, would reinstate the stronger protections for the chemical abortion pill mifepristone …Continue reading "Court orders FDA’s original safety regulations be reinstated for dangerous abortion poison pills"
By Dave Andrusko At the end of the week, we’re taking still another look at this week’s important decision by a panel of judges from the 5th U.S. Circuit Court of Appeals which “found unlawful the Biden administration’s mail-order drug regimen and held that the FDA must restore important safeguards on chemical abortion drugs,” in the words of Erin …Continue reading "5th Circuit Court of Appeals imposes restrictions on abortion pill mifepristone, however drug will stay on the market for now — Part Three"